TXG
10x Genomics, Inc.
NasdaqGS · USD · Stock
$70.11
-19.93 (-22.13%)
past month
Closed- Market cap
- $9.13B
- Volume
- 5.2M
- 52 weeks
- $12.80 – $103
About
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.
10x Genomics, Inc. (TXG) is a healthcare company listed on Nasdaq, traded in USD. Over the past year it moved between $12.80 and $102.81. The 14 analysts covering it say Buy, with an average price target of $77.50. Its next earnings report is on November 5, 2026.
- Healthcare
- Medical Devices
- Pleasanton, United States
- 1.2K employees
- Led by Serge Saxonov Ph.D.
Coming up
Earnings
Next report
Expected EPS -$0.0200 · revenue $147.85M
Financials
Revenue, last 12 months
$616.91M-12.70%
Earnings
Beat the estimate
4 of 4 quarters
Q3 2025
+67.43%
Q4 2025
+276.25%
Q1 2026
+219.15%
Q2 2026
+258.37%
Earnings per share, last 12 months -$0.5900
Analysts
14 analysts say
Buy
12-month target$77.50+10.54%
Ownership
- Institutions
- 117.29%
- Insiders
- 1.44%
Latest insider trade Sep 22, 2026, SULIMAN SHEHNAAZ
Prices from Yahoo Finance, may be delayed · Trending stocks today